Gapping up
In reaction to strong earnings/guidance: RMGN +14.3%, SHLO +4.8%, MOBI +4.2%, WUBA +3.8%
M&A news: RTI +44.4% ( Alcoa (AA) to acquire RTI for $41/share in a stock for stock ), PNK +24.7% (David Faber tweets 'Gaming and Leisure (GLPI) springs bear hug on PNK, trying to combine with its real estate assets; GLPI says deal worth $36/share to PNK holders')
Select metals/mining stocks trading higher: ABX +1.9%, AU +1.5%, GOLD +1.4%, GDX +1.3%, NEM +1.3%, MT +1%
Other news: CTIC +20.4% (CTI BioPharma and Baxter (BAX) announce positive Phase 3 persist-1 trial results of pacritinib for patients with myelofibrosis), OPXA +12.3% (amended its option and license agreement with Merck Serono (MKGAY.PK unit) and will receive a $3 mln payment), HTBX +10.2% (receives US FDA Fast Track Designation for HS-410 ), WLL +9.7% (WSJ report that the company is considering sale), CAMT +7.8% (announces the receipt of an order for 9 Eagle-i systems), PHMD +4.3% (cont strength from last week), MPO +3.5% (Interim CEO Peter Hill resigns, steps down from Board; co will appoint Frederic Brace as interim President and Chief Executive Officer), XOMA +3.1% ( presents positive Phase 1 XOMA 358 data), BXE +2.7% (proved reserves +30% in 2014, with production +74%), GM +2.6% (authorizes initial $5 bln share repurchase program beginning immediately; reaffirms FY15 EBIT targets and long term guidance), HZNP +1.6% (announces that pre-clinical data show treatment with Interferon Gamma improved signs of disease severity of rare bone disease), URBN +1.6% (favorable commentary on Friday's Mad Money), SPPI +1.4% (announces that its New Drug Application for Captisol-Enabled Melphalan has been accepted by the FDA), JACK +1% (favorable commentary on Friday's Mad Money), AAPL +0.8% (in advance of product event; also target raised to $145 from $130 at Macquarie), FCAU +0.8% (NHTSA confirms FCAU recalls certain 2008-2010 models over ignition switch issue)
Analyst comments: AVEO +14% (upgraded to Sector Perform from Underperform at RBC Capital Mkts), UTIW +4.4% (upgraded to Outperform from Mkt Perform at FBR Capital), JNPR +2.2% (upgraded to Buy from Neutral at Goldman), URBN +1.6% (target raised to $46 from $42 at Brean Capital), MPEL +1.2% (upgraded to Neutral from Underweight at JP Morgan), DRH +0.8% (upgraded to Outperform from Neutral at Robert W. Baird)
In reaction to strong earnings/guidance: RMGN +14.3%, SHLO +4.8%, MOBI +4.2%, WUBA +3.8%
M&A news: RTI +44.4% ( Alcoa (AA) to acquire RTI for $41/share in a stock for stock ), PNK +24.7% (David Faber tweets 'Gaming and Leisure (GLPI) springs bear hug on PNK, trying to combine with its real estate assets; GLPI says deal worth $36/share to PNK holders')
Select metals/mining stocks trading higher: ABX +1.9%, AU +1.5%, GOLD +1.4%, GDX +1.3%, NEM +1.3%, MT +1%
Other news: CTIC +20.4% (CTI BioPharma and Baxter (BAX) announce positive Phase 3 persist-1 trial results of pacritinib for patients with myelofibrosis), OPXA +12.3% (amended its option and license agreement with Merck Serono (MKGAY.PK unit) and will receive a $3 mln payment), HTBX +10.2% (receives US FDA Fast Track Designation for HS-410 ), WLL +9.7% (WSJ report that the company is considering sale), CAMT +7.8% (announces the receipt of an order for 9 Eagle-i systems), PHMD +4.3% (cont strength from last week), MPO +3.5% (Interim CEO Peter Hill resigns, steps down from Board; co will appoint Frederic Brace as interim President and Chief Executive Officer), XOMA +3.1% ( presents positive Phase 1 XOMA 358 data), BXE +2.7% (proved reserves +30% in 2014, with production +74%), GM +2.6% (authorizes initial $5 bln share repurchase program beginning immediately; reaffirms FY15 EBIT targets and long term guidance), HZNP +1.6% (announces that pre-clinical data show treatment with Interferon Gamma improved signs of disease severity of rare bone disease), URBN +1.6% (favorable commentary on Friday's Mad Money), SPPI +1.4% (announces that its New Drug Application for Captisol-Enabled Melphalan has been accepted by the FDA), JACK +1% (favorable commentary on Friday's Mad Money), AAPL +0.8% (in advance of product event; also target raised to $145 from $130 at Macquarie), FCAU +0.8% (NHTSA confirms FCAU recalls certain 2008-2010 models over ignition switch issue)
Analyst comments: AVEO +14% (upgraded to Sector Perform from Underperform at RBC Capital Mkts), UTIW +4.4% (upgraded to Outperform from Mkt Perform at FBR Capital), JNPR +2.2% (upgraded to Buy from Neutral at Goldman), URBN +1.6% (target raised to $46 from $42 at Brean Capital), MPEL +1.2% (upgraded to Neutral from Underweight at JP Morgan), DRH +0.8% (upgraded to Outperform from Neutral at Robert W. Baird)